Research Updates

The Allen Diabetes Center maintains a strong clinical and psychosocial research program with a primary objective of improving the lives of people with diabetes. We maintain multi-disciplinary collaborations with a variety of organizations including academic institutions, industry, and charitable foundations. Our research team maintains a strong publication record and is regularly invited to present study findings at national conferences and other scientific meetings.

Currently, the following projects are underway:

  1. Feasibility and preliminary efficacy of Viviendo Saludable: a community based lifestyle program targeting diabetes prevention and psychological well-being in Hispanic women with prediabetes: This study focusses on improving clinical and psychosocial outcomes in undeserved Hispanic women with prediabetes by engaging them in a 23-week psychosocial educational intervention.
  2. Evaluating patient engagement and other outcomes for ethnically diverse patients with type 2 diabetes participating in a structured, physician supported, and patient-centered diabetes education program: The study will improve our understanding of various provider and patient related factors that may impact patient engagement in diabetes education programs. Findings from the study will be used to develop an outcomes based, patient-centered education program for people with type 2 diabetes with optimal engagement from their physicians.
  3. Evaluation of patient-related expectations from their healthcare professionals regarding information about oral medication: results from a multi-ethnic cohort with type 2 diabetes: This study was partly funded by a grant from the Western University and will be conducted in collaboration with Dr. David Pham. The project will help explore the type of information, patients with type 2 diabetes from different ethnic groups expect from their physicians regarding diabetes medications. Findings will inform development of a toolkit that patients can use to seek important information about their diabetes medications.

If you would like further information about the program, studies undertaken or discuss collaboration opportunities, please contact: Harsimran “Sim” Singh, PhD at [email protected].